Seer, Inc.
About Seer, Inc.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $16.6M
- Net income
- -$73.6M
- Total assets
- $296.1M
- Market cap
- $98.4M
- Gross margin
- 51.1%
- Operating margin
- -470.5%
- Net margin
- -444.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $16.6M
- Cost of revenue
- $8.1M
- Gross profit
- $8.5M
- Operating expenses
- $86.5M
- Operating income
- -$78.0M
- Income tax
- $201.0K
- Net income
- -$73.6M
Balance sheet
- Total assets
- $296.1M
- Current assets
- $201.5M
- Total liabilities
- $36.8M
- Current liabilities
- $15.7M
- Shareholders’ equity
- $259.3M
Cash flow
- Operating cash flow
- -$44.4M
- Investing cash flow
- $61.5M
- Financing cash flow
- -$10.6M
- Net cash flow
- $6.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $98.4M
- Shares outstanding
- 55.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 4, 2020
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $73.6M in FY2025.
- Revenue grew 151% from FY2021 to FY2025.
- Gross margin of 51.1%, net margin -444.0%.
- Trading 24% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Seer, Inc..
Write a review
News about Seer, Inc.
News & sentiment via Polygon.io
